“…The reaction was performed following general procedure A: N -(4-( tert -butyldimethylsilyl)hex-5-yn-1-yl)-4-nitrobenzenesulfonamide ( 6f ; 50 mg, 0.13 mmol, 1.0 equiv) in CHCl 3 (3 mL), NIS (28 mg, 0.13 mmol, 1.0 equiv) was added at 0 °C, reaction temperature 0 °C, reaction time 2.5 h. Column chromatography (eluent: DCM/Hex: 30 → 40%) afforded silyl pyrrolidine 7i (17 mg, 26%) as an amorphous solid. Compound 7i (2 mg) was suspended in DCM (0.6 mL) and EtOH (0.3 mL), heated in an oil bath at 70 °C until dissolution and left to recrystallize to afford monocrystals suitable for X-ray crystallography analysis, mp 160–161 °C (decomposes >165 °C). 1 H NMR (500 MHz, CDCl 3 ): δ 8.40 (d, 2H, J = 8.9), 8.12 (d, 2H, J = 8.9), 6.65 (d, 1H, J = 0.8), 4.25 (dd, 1H, J = 9.5, 7.4), 3.56 (dt, 1H, J = 11.3, 6.7), 3.50 (ddd, 1H, J = 11.3, 8.0, 2.3), 2.02 (ddtd, 1H, J = 14.1, 13.1, 6.7, 2.2), 1.85 (ddq, 1H, J = 13.1, 6.8, 2.3), 1.80–1.65 (m, 1H), 1.36–1.26 (m, 1H), 0.94 (s, 9H), 0.31 (s, 3H), 0.28 (s, 3H).…”